Clinical Trial Update: the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating carbetocin to reduce intraoperative blood loss during abdominal myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Myomectomy-related Conditions
• Uterine Fibroid Disease

Drugs mentioned

• Carbetocin (carbetocin)

Snippet

Sponsor: Cairo University | Conditions: Abdominal Myomectomy | Phase 4 | Status: COMPLETED